Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01869777 · OUTCOME

Length of Hospitalization

Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · Source last updated 2020-08-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
Days
Interval / dispersion
Standard Deviation
Time frame
Up to 2 years

What was measured

A linear model will be used to look at the association of standardized phase angle and length of hospital stay.

Groups in this outcome

Diagnostic (Bioelectric Impedance Analysis)

Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diagnostic (Bioelectric Impedance Analysis)101

Reported measurements

Source class 1
Values in Days · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Diagnostic (Bioelectric Impedance Analysis)34.211.9Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        11.9
        value
        34.2
denoms
  1. counts
    1. group Id
      OG000
      value
      101
    units
    Participants
description
A linear model will be used to look at the association of standardized phase angle and length of hospital stay.
dispersion Type
Standard Deviation
groups
  1. description
    Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis
    id
    OG000
    title
    Diagnostic (Bioelectric Impedance Analysis)
param Type
MEAN
reporting Status
POSTED
time Frame
Up to 2 years
title
Length of Hospitalization
type
SECONDARY
unit Of Measure
Days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice